PVPaolo Verze

Paolo Verze

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paolo Verze has a total of 254 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sexual life after prostatectomy, analysis through machine learning and statistical methods

    by Sayna Rotbei, Luigi Napolitano, Stefania Zinno, Claudia Collà Ruvolo, Simone Cilio, Paolo Verze, Alessio Botta

    Prostate cancer is one of the most common malignancies in men. It can be treated with prostatectomy, a surgical procedure that may result in postoperative sexual dysfunction. To effectively counsel patients and to anticipate potential complications, this work adopts traditional statistical methods and machine learning to predict patients’ sexual satisfaction one year post-surgery. A retrospective, single-center cohort study was conducted involving 409 patients, with a median age of 72 years. This cohort was derived from an initial population of 524 individuals, following the exclusion of cases with incomplete EPIC-26 Q12 data at the 12-month follow-up. We studied medical patients from the University Hospital of Naples “Federico II”, focusing on evaluations before and one year after surgery. Patients’ satisfaction with their sexual function was measured using question 12 from the Expanded Prostate Index Composite (EPIC-26). Statistical results showed a positive link between the International Prostate Symptom Score (IPSS) and sexual dissatisfaction after surgery. Pre-operative higher IPSS scores were associated with lower sexual satisfaction. However, most patients did not experience a significant drop in sexual satisfaction one year after surgery. Scores on the International Index of Erectile Function (IIEF) and EPIC-26-Q12 exhibit, in fact, an interesting inverse relationship, indicating that higher pre-operative scores on one correspond to lower scores on the other. Machine learning techniques on the other hand, allow a prediction accuracy of 81% for post-operative sexual impairment, with the Extra-Trees classifier yielding the best performance. The achieved prediction accuracy of 81% suggests that machine learning models may serve as valuable tools for preoperative risk stratification and for providing personalized patient counseling regarding postoperative sexual function. This study shows how the combination of statistical approaches and machine learning can improve sexual health management after prostate radical surgery, providing insights for doctors and patients, while further validation involving larger and multicenter datasets is necessary, these findings underscore the significant clinical potential of incorporating statistical and machine learning methodologies into the management of postoperative sexual health.

  • Open Access

    Anastomotic Renal Sinus Haemangioma—A Case Report

    by Mariella Izzo, Francesco Negri, Rosario Gnazzo, Nicola Bertini, Francesco Verrengia, Simona Petrosino, Simone Cilio, Paolo Verze, Vincenzo Ciccone

    Vascular tumours of the kidney are a heterogeneous group of lesions showing common characteristics with malignant neoplasms, making it significantly challenging the pre-operative diagnosis. Among these lesions, anastomotic hemangioma (AH) is a recently recognised variant of hemangioma of the genito-urinary tract characterized by a complex vascular structure. In this case report, we present the case of an 85-year-old patient with an incidental diagnosis of renal mass. The multidisciplinary decision to proceed with nephrectomy, with subsequent benign histological result, highlights the uncertainty surrounding the preoperative evaluation of renal tumours This case highlights the importance of evaluation and multidisciplinary approach in the management of renal masses, particularly for rare lesions such as AH. Knowledge of these pathological entities is crucial for clinicians to avoid misdiagnosis and inappropriate treatment and to improve the quality of care in patients with renal tumours. Increasing awareness of these variants may also influence improvement in imaging strategies and diagnostic guidelines, promoting a more conservative approach in the presence of suspicious, but potentially benign, lesions.


  • Open Access

    Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study

    by Giuseppe Di Lorenzo, Carlo Buonerba, Raffaele Baio, Oriana Strianese, Francesca Cappuccio, Antonio Verde, Alessia Nunzia Calabrese, Vittorino Montanaro, Federica Fortino, Antonio Tufano, et al.

    Background and Objectives: Environmental pollution in regions like the Sarno River Basin in southern Italy significantly affects physical and psychological health. This study aimed to validate three novel psychometric tools—REST, HEAL-BDLC, and PEACE—for assessing fatigue, mood disturbances, and sleep quality in environmentally exposed populations. While correlations with heavy metal exposure will be addressed in a separate manuscript, this study focuses solely on psychometric validation. Materials and Methods: The PREVES-STOP Initiative recruited 88 participants aged 30–65 years from the Sarno River Basin. Participants completed psychometric questionnaires tailored to measure fatigue (REST), symptoms of depression and anxiety (HEAL-BDLC), and sleep quality (PEACE). Internal consistency, construct validity, and reliability were analyzed using Cronbach’s alpha, correlation analyses, and principal component analysis (PCA). A subgroup received a nutraceutical intervention for us to explore their responsiveness to change over a two-week period. Results: REST (α = 0.969), HEAL-BDLC (α = 0.962), and PEACE (α = 0.736) demonstrated strong reliability. PCA confirmed the unidimensional structure of REST and the two-component structure of HEAL-BDLC (depression and anxiety dimensions) and PEACE (insomnia and sleep quality). Correlations with established measures, such as the WHO Well-Being Index, supported construct validity. Among the intervention participants, significant improvements were observed in fatigue (−12.5 REST median score), mood (−13.0 HEAL-BDLC median score), sleep (+1.5 PEACE median score), and overall well-being (+4.0 WHO-5 median score). Conclusions: REST, HEAL-BDLC, and PEACE are reliable and valid instruments for assessing nuanced health outcomes in environmentally exposed populations. They hold potential for guiding public health interventions and evaluating environmental remediation impacts. These findings lay the groundwork for future studies linking psychometric outcomes with heavy metal exposure.


  • Open Access

    The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study

    by Giuseppe Di Lorenzo, Antonio Verde, Luca Scafuri, Ferdinando Costabile, Vincenza Caputo, Rossella Di Trolio, Oriana Strianese, Vittorino Montanaro, Felice Crocetto, Francesco Del Giudice, et al.

    Background: Oxidative stress has emerged as a key contributor to numerous NCDs (non-communicable diseases), including cardiovascular diseases, cancer, and diabetes. This study aims to explore the potential of targeted interventions to mitigate oxidative stress as part of a primary prevention strategy. Methods: The study included 32 healthy participants (11 men, 21 women) aged 45–65 who completed both the initial and follow-up assessments of the Healthy Days Initiative, a community-based wellness program organized by the non-profit Associazione O.R.A. ETS. Through blood analysis, vital sign assessment, lifestyle questionnaires, and individualized recommendations, participants received guidance on improving their health and reducing disease risk. The initiative also offered the opportunity for participants to consume a flavonoid supplement containing quercitrin, rutin, and hesperidin, with the goal of reducing oxidative stress. Participants who opted for supplementation were instructed to take 1–2 tablets daily for two weeks. Data collected included demographic information, anthropometric measurements, vital signs, dietary and lifestyle habits, medical history, WHO-5 Well-Being Index scores, and blood parameters. Results: Significant reductions were observed in glucose levels (from 82 to 74.5 mg/dL), reactive oxygen metabolites (d-ROMs) (from 394.5 to 365.5 U.CARR), and systolic blood pressure (from 133 to 122 mmHg) after the two-week flavonoid intervention. Most participants (26/31) reported no side effects, and the majority (30/31) expressed a willingness to continue using a product combination of quercitrin, rutin, and hesperidin or a similar product long-term. Conclusions: While limited in scope and duration, the PREVES-FLAVON study contributes valuable insights to the growing body of evidence suggesting that flavonoid supplementation may play a significant role in reducing risk factors associated with NCDs in primary prevention settings. By targeting novel risk factors such as oxidative stress, this intervention holds promise for mitigating the global burden of NCDs and promoting healthy aging.


  • Open Access

    The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMS Test in the General Population: The PREVES – FLAVON Retrospective Observational Study

    by Giuseppe Di Lorenzo, Antonio Verde, Luca Scafuri, Ferdinando Costabile, Vincenza Caputo, Rossella Di Trolio, Oriana Strianese, Vittorino Montanaro, Felice Crocetto, Francesco Del Giudice, et al.

    Background: Oxidative stress has emerged as a key contributor to numerous NCDs (Non Communicable Diseases), including cardiovascular diseases, cancer, and diabetes. This study aims to explore the potential of targeted interventions to mitigate oxidative stress as part of a primary prevention strategy. Methods: The study included 32 healthy participants (11 men, 21 women) aged 45-65 who completed both the initial and follow-up assessments of the Healthy Days Initiative, a community-based wellness program organized by the non-profit Associazione O.R.A. ETS. Through blood analysis, vital sign assessment, lifestyle questionnaires, and individualized recommendations, participants received guidance on improving their health and reducing disease risk. The initiative also offered the opportunity for participants to consume a flavonoid supplement containing quercitrin, rutin and hesperidin, with the goal of reducing oxidative stress. Participants who opted for supplementation were instructed to take 1-2 tablets daily for two weeks. Data collected included demographic information, anthropometric measurements, vital signs, dietary and lifestyle habits, medical history, WHO-5 Well-Being Index scores, and blood parameters. Results: Significant reductions were observed in glucose levels (from 82 to 74.5 mg/dL), reactive oxygen metabolites (d-ROMs) (from 394.5 to 365.5 U.CARR), and systolic blood pressure (from 133 to 122 mmHg) after the two-week flavonoid intervention. Most participants (26/31) reported no side effects, and the majority (30/31) expressed a willingness to continue using a product combination of quercitrin, rutin and hesperidin or a similar product long-term. Conclusions: While limited in scope and duration, the PREVES-FLAVON study contributes valuable insights to the growing body of evidence suggesting that flavonoid supplementation may play a significant role in reducing risk factors associated with NCDs in primary prevention settings. By targeting novel risk factors such as oxidative stress, this intervention holds promise for mitigating the global burden of NCDs and promoting healthy aging.


  • Acute Bacterial Prostatitis

    by Paolo Verze, Massimiliano Creta, Gianluigi Califano, Alessandro Palmieri

  • Open Access

    Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review

    by Achille Aveta, Simone Cilio, Roberto Contieri, Gianluca Spena, Luigi Napolitano, Celeste Manfredi, Antonio Franco, Fabio Crocerossa, Clara Cerrato, Matteo Ferro, et al.

    MicroRNAs (miRNAs) are emerging as biomarkers for the detection and prognosis of cancers due to their inherent stability and resilience. To summarize the evidence regarding the role of urinary miRNAs (umiRNAs) in the detection, prognosis, and therapy of genitourinary cancers, we performed a systematic review of the most important scientific databases using the following keywords: (urinary miRNA) AND (prostate cancer); (urinary miRNA) AND (bladder cancer); (urinary miRNA) AND (renal cancer); (urinary miRNA) AND (testicular cancer); (urinary miRNA) AND (urothelial cancer). Of all, 1364 articles were screened. Only original studies in the English language on human specimens were considered for inclusion in our systematic review. Thus, a convenient sample of 60 original articles was identified. UmiRNAs are up- or downregulated in prostate cancer and may serve as potential non-invasive molecular biomarkers. Several umiRNAs have been identified as diagnostic biomarkers of urothelial carcinoma and bladder cancer (BC), allowing us to discriminate malignant from nonmalignant forms of hematuria. UmiRNAs could serve as therapeutic targets or recurrence markers of non-muscle-invasive BC and could predict the aggressivity and prognosis of muscle-invasive BC. In renal cell carcinoma, miRNAs have been identified as predictors of tumor detection, aggressiveness, and progression to metastasis. UmiRNAs could play an important role in the diagnosis, prognosis, and therapy of urological cancers.


  • Open Access

    Urinary Micro-RNAs As Biomarkers of Urological Cancers: A Systematic Review

    by Achille Aveta, Simone Cilio, Roberto Contieri, Gianluca Spena, Luigi Napolitano, Celeste Manfredi, Antonio Franco, Fabio Crocerossa, Clara Cerrato, Matteo Ferro, et al.

    Background: Micro-RNAs (miRNA) are emerging as biomarkers in the detection and prognosis of cancers due to their inherent stability and resilience. Methods: To summarize evidence regarding urinary miRNA (umiRNAs) role in the detection, prognosis and therapeutic management of urological cancers, we performed a systematic review of the most important scientific databases using the following keywords: (urinary mir-na)AND(prostate cancer); (urinary mirna)AND(bladder cancer); (urinary mirna)AND(renal cancer); (urinary mirna)AND(testicular cancer); (urinary mirna)AND(urothelial cancer). Results: Of all, 1364 articles were initially selected. Only original studies in the English language on human specimens were considered for inclusion in our systematic review. Thus, a convenient sample of 60 original articles was identified. Urinary miRNA (UmiRNAs) are downregulated in prostate cancers and may serve as potential non-invasive molecular biomarkers. Several umiR-NAs have been identified as diagnostic biomarkers of urothelial carcinoma and bladder cancer (BCa), allowing to discriminate malignant from non-malignant forms of haematuria. UmiRNAs could serve as therapeutic targets or recurrence markers of non-muscle invasive BCa and could predict the aggressivity and prognosis of muscle-invasive BCa. In renal cell carcinoma, miRNAs have been identified as predictors of tumour detection, aggressiveness, and progression to metastasis. Conclusion: umiRNAs could play an important role in the diagnosis, prognosis, and therapy of urological cancers.


  • History of penile implants: from implants made of bone to modern inflatable penile implants

    by Alessandro Giordano, Francesco Smarrazzo, Simone Cilio, Gianluigi Califano, Claudia Collà Ruvolo, Paolo Verze

    Penile prostheses are implantable devices used to definitively treat erectile dysfunction when previous forms of treatment have failed. The first example of a penile implant dates to 1935, when a rib was inserted in a neo-phallus reconstructed after a traumatic amputation. Since then, alternative artificial devices were adopted as penile prosthetic implants. The evolution of prosthetic devices had a dramatic thrust in 1973 when the first inflatable penile prosthesis was worldwide presented. Thanks to advances in device materials, design, surgical implant techniques, and perioperative management, nowadays inflatable penile prostheses are one of the most adopted definitive therapy for patients with drug-refractory erectile dysfunction or refusing alternative forms of treatments. Moreover, the clinical indications for inflatable penile prosthesis have also expanded, including female-to-male transmen or men underwent penile reconstruction due to congenital aphallia or traumatic or surgical penile amputation. In order to summarise the process behind the development and evolution of penile prosthesis, we aimed at performing a historical review of the currently available literature to provide an easy and comprehensive overview of the topic. The understanding of the historical process behind the evolution of inflatable penile prostheses will drive further innovation to increase efficiency and the rate of patients satisfaction.


  • Open Access

    A Novel Low-Cost Uroflowmetry for Patient Telemonitoring

    by Savio Domenico Pandolfo, Federica Crauso, Achille Aveta, Simone Cilio, Biagio Barone, Luigi Napolitano, Antonio Scarpato, Benito Fabio Mirto, Francesco Serino, Francesco Del Giudice, et al.

    Uroflowmetry (UF) is a crucial guideline-recommended tool for men with benign prostatic obstruction (BPO). Moreover, UF is a helpful decision-making tool for the management of patients with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). In the last few years, telemedicine and telehealth have increased exponentially as cost-effective treatment options for both patients and physicians. Telemedicine and telehealth have been well positioned during the COVID-19 pandemic to prevent healthcare system overload and to ensure adequate management of patients through screening, diagnosis, and follow-up at home. In the present manuscript, the main characteristics and performance of a novel and low-cost device for home-based UF have been analyzed. The simple weight-transducer method has been applied to perform UF. An inexpensive load cell connected to a 24 bit analogic digital converter (ADC) sends data to a cloud server via SIM card or home Wi-Fi. Data are processed and shown in graphics with both volume and flow rate as a function of time, allowing for measurement of average flow rate, maximum flow rate, voided volume, and voiding time. A numerical algorithm allows for filtering of the dynamic effect due to the urine gravity acceleration and for removing the funnel to simplify the home measurement procedure. Through an online platform, the physician can see and compare each UF data. The device’s reliability has been validated in a first laboratory setting and showed excellent performance. This approach based on domiciliary tests and an online platform can revolutionize the urologic clinic landscape by offering a constant patient cost-effective follow-up, eliminating the time wasted waiting in the office setting.